Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma

被引:4
作者
Furukawa, Daisuke [1 ,2 ,3 ]
Chijiwa, Tsuyoshi [4 ]
Matsuyama, Masahiro [3 ]
Mukai, Masaya [5 ]
Matsuo, Ei-Ichi [6 ]
Nishimura, Osamu [7 ]
Kawai, Kenji [4 ]
Suemizu, Hiroshi [4 ]
Nakagohri, Toshio [3 ]
Ozawa, Soji [3 ]
Shimada, Kazuaki [8 ]
Hiraoka, Nobuyoshi [1 ,2 ]
Nakamura, Masato [9 ]
机构
[1] Natl Canc Ctr, Res Inst, Div Pathol & Clin Labs, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 1040045, Japan
[3] Tokai Univ, Sch Med, Dept Surg, Isehara, Kanagawa 2591193, Japan
[4] Cent Inst Expt Anim, Kawasaki, Kanagawa 2100821, Japan
[5] Tokai Univ, Hachioji Hosp, Dept Surg, Hachioji, Tokyo 1920032, Japan
[6] Shimadzu Co Ltd, Global Applicat Dev Ctr, Kyoto 6048511, Japan
[7] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan
[8] Natl Canc Ctr, Res Inst, Div Hepatobiliary & Pancreat Surg, Tokyo 1040045, Japan
[9] Tokai Univ, Sch Med, Dept Regenerat Med, Isehara, Kanagawa 2591193, Japan
关键词
zinc finger protein 185; pancreatic ductal carcinoma; prognosis; hematogenous metastasis; subcellular location; LIVER METASTASIS; COLON-CANCER; PAXILLIN; GEMCITABINE; PROTEIN;
D O I
10.3892/ol.2017.6633
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic ductal carcinoma (PDC) is one of the major causes of cancer-associated mortality globally due to its high potential for distant metastasis. To understand hematogenous metastasis, the molecular expression profiles of weak metastatic PDC cell subline BxPC-3 and highly liver-metastatic cell subline LM-BxPC-3 were compared, and zinc finger protein 185 (ZNF185) was identified as a molecule that is upregulated in LM-BxPC-3 cells. The aim of the present study was to evaluate the clinicopathological significance of ZNF185 in PDC. Using immunohistochemistry, ZNF185 expression was investigated in 182 patients with PDC, in association with numerous clinicopathological variables. The expression profile of ZNF185 was also characterized using xenograft models. In contrast to parent BxPC-3 cells in subcutaneous transplanted tumor foci, which only expressed ZNF185 on their plasma membrane (m)ZNF185, LM-BxPC-3 cells in liver-metastatic foci that were formed subsequent to transplantation all expressed cytoplasmic (c)ZNF185. Additionally, 51% of the cells at the periphery of the tumor foci expressed mZNF185. Expression of cZNF185, and of mZNF185 and cZNF185 combined was identified in 93 and 39% of clinical patients with PDC, respectively. Patients with mZNF185-negative and-positive PDC exhibited a median survival time of 30.2 months and 21.3 months, respectively. Multivariate analysis indicated that the expression of mZNF185 is closely associated with a shorter overall survival time. Increased marked venous invasion was more prevalent in patients who were mZNF185-positive, as compared with patients who were mZNF185-negative. These data suggest that the expression of mZNF185 is an independent and unfavorable prognosticator in patients with PDC. The results suggested that the amount and subcellular location of ZNF185 are correlated with the position of the cancer cells expressing it within the nests. Additionally, the subcellular location of ZNF185 may be important to its biological function.
引用
收藏
页码:3633 / 3640
页数:8
相关论文
共 50 条
  • [31] Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma
    Vay, Christian
    Babaei, Shahrooz
    Safi, Sami-Alexander
    Dizdar, Levent
    Rehders, Alexander
    Haeberle, Lena
    Roderburg, Christoph
    Loosen, Sven H.
    Esposito, Irene
    Knoefel, Wolfram T.
    Krieg, Andreas
    CANCERS, 2022, 14 (14)
  • [32] DNA CONTENT AS PROGNOSTIC FACTOR IN RESECTED PANCREATIC-CARCINOMA
    SCHWAB, G
    WEGER, AR
    POINTNER, R
    AUER, G
    MIKUZ, G
    BODNER, E
    DIGESTIVE SURGERY, 1990, 7 (01) : 8 - 12
  • [33] TISSUE FACTOR PATHWAY INHIBITOR-2 AS A PROGNOSTIC FACTOR IN PANCREATIC CARCINOMA
    俞建雄
    袁静
    王春友
    MedicalBulletinofShanghaiJiaotongUniversity, 2013, 25 (01) : 12 - 18
  • [34] Immunohistochemical Evaluation of the Expression of Specific Membrane Antigens in Patients with Pancreatic Ductal Adenocarcinoma
    Nicoletti, Alberto
    Vitale, Federica
    Quero, Giuseppe
    Paratore, Mattia
    Fiorillo, Claudio
    Negri, Marcantonio
    Carlino, Angela
    Inzani, Frediano
    Gasbarrini, Antonio
    Alfieri, Sergio
    Dal Verme, Lorenzo Zileri
    CANCERS, 2023, 15 (18)
  • [35] Initial Metastatic Site as a Prognostic Factor in Patients With Stage IV Pancreatic Ductal Adenocarcinoma
    Kim, Hyoung Woo
    Lee, Jong-chan
    Paik, Kyu-hyun
    Lee, Yoon Suk
    Hwang, Jin-Hyeok
    Kim, Jaihwan
    MEDICINE, 2015, 94 (25) : e1012
  • [36] Exploring the prognostic value of circular RNAs in pancreatic ductal adenocarcinoma using genome-wide expression profiling
    Orbeck, Siri Vreim
    Jakobsen, Theresa
    Garcia-Rodriguez, Juan Luis
    Burton, Mark
    Rasmussen, Lukas Gammelgaard
    Ewald, Jesper Dupont
    Fristrup, Claus Wilki
    Pfeiffer, Per
    Mortensen, Michael Bau
    Kristensen, Lasse Sommer
    Detlefsen, Sonke
    PANCREATOLOGY, 2024, 24 (05) : 706 - 718
  • [37] WT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma
    Li, Bing-Qi
    Huang, Shuai
    Shao, Qian-Qian
    Sun, Jian
    Zhou, Li
    You, Lei
    Zhang, Tai-Ping
    Liao, Quan
    Guo, Jun-Chao
    Zhao, Yu-Pei
    ONCOLOGY LETTERS, 2017, 13 (04) : 2531 - 2538
  • [38] Expression, clinicopathologic, and prognostic significance of MMP15 in operable pancreatic ductal adenocarcinoma
    Liu Wen-Jing
    Liu Jian-Zhou
    Zhou Wei-Xun
    Zhou Li
    Guo Jun-Chao
    胰腺病学杂志(英文), 2023, 06 (03)
  • [39] Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma
    Jianli Zhang
    Xiuli Jiang
    Jian Zhang
    World Journal of Surgical Oncology, 12
  • [40] Prognostic Impact of Cell Division Cycle Associated 2 Expression on Pancreatic Ductal Adenocarcinoma
    Meng-yi Wang
    Zhe-yu Niu
    Xiang-Gao
    Li Zhou
    Quan Liao
    Yu-pei Zhao
    Chinese Medical Sciences Journal, 2016, 31 (03) : 149 - 154